DWA
ZYME icon

Dorsey Wright & Associates’s Zymeworks ZYME Stock Holding History

Dorsey Wright & Associates’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-399
Closed -$15K – 375
2020
Q2 		$15K Hold
399
– – ﹤0.01% 182
2020
Q1 		$14K Sell
399
-29
-7% -$1.19K 0.01% 118
2019
Q4 		$19K Hold
428
– – 0.01% 131
2019
Q3 		$11K Buy
+428
New +$10.7K ﹤0.01% 230

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Dorsey Wright & Associates's ZYME Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 399 shares — an estimated $15K sold.

Dorsey Wright & Associates first reported a position in ZYME in Q3 2019 and held it in 4 quarters. The position peaked at $19K in Q4 2019. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 399 Zymeworks shares in Q3 2020, an estimated $15K.
  • Dorsey Wright & Associates first reported a position in Zymeworks in Q3 2019 and held it in 4 quarters.
  • Dorsey Wright & Associates's Zymeworks position peaked at $19K in Q4 2019.
  • 127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.